|
NCI Extramural Support
|
Extramural Support
|
$5,214,000
|
$5,214,000
|
NA
|
NCI (NCI)
|
|
Training Program in Cancer Biology
|
5T32CA078207-19
|
$554,252
|
|
AARONSON, STUART
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Modeling bladder cancer pathogenesis and tumor evolution
|
1P01CA221757-01A1
|
$1,765,498
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
|
2R01CA173481-06
|
$385,883
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
A Mouse Model for Prostate Cancer
|
5U01CA084294-09
|
$1,212,233
|
$606,117
|
Abate-Shen, Cory
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer
|
1R37CA222294-01A1
|
$366,000
|
|
ABAZEED, MOHAMED
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Novel platform linking cancer-specific glycosylation with cell signaling outcomes
|
1R21CA229044-01
|
$225,250
|
|
ABBOTT, KAREN
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Discovery of Alpha-MSH Analogs for Skin Cancer Prevention
|
5R01CA114095-02
|
$302,740
|
$302,740
|
ABDEL-MALEK, ZALFA
|
UNIVERSITY OF CINCINNATI
|
|
Center for Multiple Myeloma Nanotherapy
|
5U54CA199092-04
|
$2,184,301
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Identifying molecular drivers of tumor heterogeneity in pancreatic cancer
|
1F31CA224792-01A1
|
$36,672
|
|
ADAMS, CHRISTINA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-04
|
$568,727
|
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Discovery and Characterization of Mutations in Breast and Ovarian Cancers
|
5R50CA211280-03
|
$215,047
|
|
ADAMSON, AARON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Genetic identification of novel mTORC1 regulators and homeostatic signaling mechanisms
|
1F31CA228241-01
|
$44,524
|
|
ADELMANN, CHARLES
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
University of North Carolina Womens Interagency HIV Study UNC WIHS
|
3U01AI103390-05S1
|
$60,652
|
|
ADIMORA, ADAORA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors
|
1R01CA236615-01
|
$392,764
|
|
ADUSUMILLI, PRASAD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Plumbagin in Combination with Vemurafenib for BRAF-mutant Melanoma
|
5R03CA212798-02
|
$74,250
|
|
AFAQ, FARRUKH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Genetics of Graft-versus-Host Disease
|
1R01CA231141-01
|
$265,229
|
|
AFSHAR-KHARGHAN, VAHID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
New Roles for the WTX Tumor Suppressor and Endocytosis in WNT signaling
|
1F31CA228289-01
|
$34,190
|
|
AGAJANIAN, MEGAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
|
3R01CA195708-05S1
|
$94,087
|
$94,087
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Prostate Cancer Prevention by Procyanidins in Grape Seed
|
5R01CA091883-05
|
$322,524
|
$322,524
|
AGARWAL, CHAPLA
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
Prostate cancer prevention and treatment by sillibinin
|
5R01CA102514-05
|
$322,762
|
$322,762
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
Colon Cancer Chemoprevention by Flavonoid Silibinin
|
5R01CA112304-03
|
$284,889
|
$284,889
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
Angioprevention of Lung Tumorigenesis by Silibinin
|
5R01CA113876-03
|
$283,140
|
$283,140
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
Cancer Chemoprevention by IP6: Efficacy and Mechanism
|
5R01CA116636-02
|
$261,552
|
$261,552
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
SELECT Pre-Clinical Trial of Prostate Cancer
|
5R01CA114060-02
|
$250,774
|
$250,774
|
Ahmad, Nihal
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Phase III Trial of Selenium for Prostate Cancer Prevention
|
5R01CA077789-09
|
$605,351
|
$605,351
|
Ahmann, Frederick
|
UNIVERSITY OF ARIZONA
|
|
Mutagenesis and migration in glioblastoma cells
|
1R21CA220111-01A1
|
$179,240
|
|
AHN, EUN HYUN
|
UNIVERSITY OF WASHINGTON
|
|
Chemoprevention of arsenic-induced skin cancer
|
7R01CA107431-03
|
$1,563,352
|
$1,563,352
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
|
Mapping cancer micro-environments for acute leukemia
|
5R01CA202025-03
|
$455,870
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Metabolic Syndrome and Epigenetic Markers of Breast Cancer in Nigerian Women
|
5K01TW010271-03
|
$134,531
|
|
AKINYEMIJU, TOMI
|
UNIVERSITY OF KENTUCKY
|
|
Prevention of Metastatic Cancer Using a Novel Vitamin E Analog
|
1R01CA120552-01A1
|
$258,210
|
$258,210
|
AKPORIAYE, EMMANUEL
|
UNIVERSITY OF ARIZONA
|
|
Studies of Alpha-tocopherol and Beta-Carotene in Finland
|
Z01 CP010195
|
$742,362
|
$135,377
|
Albanes
|
DCEG (NCI)
|
|
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
|
1P01CA217805-01A1
|
$2,105,511
|
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S1
|
$363,313
|
$178,023
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S2
|
$113,227
|
$55,481
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S3
|
$327,884
|
$160,663
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S4
|
$88,172
|
$43,204
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
CHEMOPREVENTION OF SKIN CANCER PROGRAM PROJECT
|
5P01CA027502-26
|
$3,758,432
|
$3,758,432
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
5P30CA023074-30
|
$4,124,404
|
$2,020,958
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Cancer Prevention and Control Health Disparities Training Program
|
5T32CA078447-18
|
$161,530
|
$32,306
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Genomic Analysis of ER Negative Breast Cancer
|
5R01CA101359-05
|
$359,123
|
$359,123
|
Albertson, Donna
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Modulation of wild type and mutant p53 by HMGA1
|
1F32CA221010-01A1
|
$58,654
|
|
ALEXANDER, KATHERINE
|
UNIVERSITY OF PENNSYLVANIA
|
|
p63 as a novel factor promoting pregnancy-induced HER2-positive breast cancer
|
5K22CA190653-03
|
$157,743
|
|
ALEXANDROVA, EVGUENIA
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
|
5F30CA220847-02
|
$49,524
|
|
ALI, MOIEZ
|
DUKE UNIVERSITY
|
|
Profiling signaling activity and gene expression in single, pancreatic adenocarcinoma cells using CE-RNA-Seq
|
1R01CA224763-01A1
|
$575,272
|
|
ALLBRITTON, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Single-Cell Measurement of Lipid Signaling in Colorectal Cancer
|
5R01CA177993-05
|
$575,397
|
|
ALLBRITTON, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancers
|
5P01CA196539-04
|
$1,855,117
|
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-05
|
$435,560
|
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Novel Molecular Therapies of Prostate Cancer
|
5P01CA140043-09
|
$1,222,825
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Tumor Plasticity
|
5R35CA220446-02
|
$1,140,000
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
Total relevant funding to Chemoprevention for this search: $200,392,998
|